Byetta Litigation

Byetta Litigation

As of 8/18/2008, the FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta. Of the 6 cases of hemorrhagic or necrotizing pancreatitis, all patients required hospitalization, two patients died and four patients were recovering at time of reporting.

Byetta (exenatide) is a medicine given by injection to help adults with type 2 diabetes improve blood sugar control. Byetta is typically self-injected.

An 8/18/2008 letter from the FDA warned physicians of the possible association between Byetta use and hemorrhagic or necrotizing pancreatitis. The FDA also advised Healthcare professionals that they should instruct patients taking Byetta to seek prompt medical care in they experience unexplained persistent severe abdominal pain which may or may not be accompanied by vomiting.

Pancreatitis is an inflammation of the pancreas that can cause bleeding, tissue damage and infection. Severe cases of pancreatitis can lead to the release of toxins and enzymes into the blood stream that can injure the heart, lungs, kidneys or other organs. In some instances, acute pancreatitis can be fatal.

Free Case Evaluation – We offer proven representation in defective drug and products liability cases (including Byetta litigation), serving clients in the Kansas City metro area and throughout Missouri and Kansas. Call (816) 484-3776.

If you or a loved one has take Byetta and subsequently developed hemorrhagic or necrotizing pancreatitis, you should contact our Kansas City Byetta litigation office at (816) 484-3776 or by e-mail. We provide a free, one-on-one consultation with an experienced Byetta litigation attorney.

Categories: